VALIANTLAB.NS

Healthcare Drug Manufacturers - Specialty & Generic

Valiant Laboratories Limited

₹119.80

+2.46 +2.10% today

Price History

Not enough data

Key Stats

Market Cap

6.51B

Avg Volume

113,085

P/E (TTM)

42.63

EPS

₹2.81

52W High

₹132.25

52W Low

₹49.51

Div. Yield

0.0%

Valuation

P/B Ratio

2.12

P/S Ratio

2.13

EV/EBITDA

21.35

EV/Revenue

2.23

Margins

Gross Margin 26.4%

Operating Margin 22.9%

Net Margin 5.2%

EBITDA Margin 10.4%

Growth & Returns

Revenue Growth (YoY)

146.2%

Earnings Growth (YoY)

826.2%

Earnings Growth (QoQ)

1058.9%

Liquidity & Leverage

Debt / Equity

0.15

Total Cash

331.50M

Total Debt

462.12M

About

Valiant Laboratories Limited operates as an active pharmaceutical ingredient/bulk drug manufacturing company in India and internationally. The company manufactures paracetamol in various grades, such as Indian/British/European/the United States pharmacopoeias for the treatment of headaches, muscle aches, arthritis, back aches, toothaches, cold, and fever. It also manufactures and sells specialty chemicals and chemical intermediates, including chlorophenol derivatives, benzene-based specialty chemicals and other chemical intermediates to agrochemicals, pharmaceuticals, dyes and pigments, polymers, personal care, and allied industries. The company was formerly known as Bharat Chemicals and changed its name to Valiant Laboratories Limited in August 2021. The company was founded in 1980 and is based in Mumbai, India.

valiantlabs.in